SAN FRANCISCO, Sept. 27, 2016
SAN FRANCISCO, Sept. 27, 2016 /PRNewswire/ -- Salesforce (NYSE:CRM), the Customer Success Platform and world's #1 CRM company, today announced that Eli Lilly and Company (NYSE: LLY) -- a Fortune 500 company and global leader in healthcare -- has expanded its use of the Salesforce Platform to develop more innovative and intuitive apps that are designed to personalize patient support programs, unite care teams and ultimately improve patient outcomes.
Since 1876, Lilly has succeeded in helping people live longer, healthier and more active lives by creating high-quality medicines that meet real patient needs. However, expectations have changed tremendously in recent years, as many patients today want their providers and pharmaceutical companies to connect with them through mobile, social and cloud technologies.
To address evolving patient needs, Lilly turned to Salesforce to help launch more than 50 apps over the last two years. These are internal and external facing apps that Lilly has used to better understand patient insights and engage in a way patients prefer. For example, Lilly TrialGuide helps patients learn about clinical trials, find one that's right for them and connect with the clinic. With its expanded use of the Salesforce Platform, Lilly is doubling down on its efforts to develop apps that will lead to more relevant and meaningful touch-points along every step of the patient journey.
Comments on the News
"Patient expectations have changed dramatically in the last five years, and developing innovative medicines is no longer enough," said Rob Brown, senior vice president and chief marketing officer at Lilly. "Today, patients want relevant and easily digestible information they can access when they need it most that will help them better understand and manage their condition. An app can be a great vehicle to help achieve this. With Salesforce, we're planning for the future, developing technologies and apps that enable us to meet patients at a point of need, rather than at a point of request or requirement -- on any device or channel."
"For the first time in history, healthcare IT is shifting toward the patient, and companies that build strong communities and connections around the medicines they provide will be able to better listen to patient needs and ultimately provide better outcomes," said Joshua Newman, M.D., chief medical officer, GM, Salesforce Healthcare and Life Sciences. "With Salesforce, Lilly is making an industry leading investment, building new apps to provide proactive support and engage patients in familiar and effective ways. By guiding patients along their treatment journeys, Lilly is truly putting them at the center of their care."
Experience Lilly at Dreamforce 2016
See first-hand how Lilly is getting smarter about patients to deliver better care with a virtual patient journey at Dreamforce 2016, October 4-7 in San Francisco. The full Lilly experience will be featured at the Salesforce Campground in Moscone South, Halls A, B and C.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.
Salesforce, the Customer Success Platform and world's #1 CRM, empowers companies to connect with their customers in a whole new way. For more information about Salesforce (NYSE: CRM), visit: www.salesforce.com.
Any unreleased services or features referenced in this or other press releases or public statements are not currently available and may not be delivered on time or at all. Customers who purchase Salesforce applications should make their purchase decisions based upon features that are currently available. Salesforce has headquarters in San Francisco, with offices in Europe and Asia, and trades on the New York Stock Exchange under the ticker symbol "CRM." For more information please visit http://www.salesforce.com, or call 1-800-NO-SOFTWARE.
This press release contains "forward-looking statements." All statements other than historical facts included in this press release, including, but not limited to, statements regarding the timing and the closing of the transaction, the financing for the transaction, the expected benefits of the transaction, prospective performance and future business plans, and any assumptions underlying any of the foregoing, are forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown, or unknown risks or uncertainties materialize, actual results could vary materially from the parties' expectations and projections. These forward-looking statements reflect Salesforce's expectations as of the date of this press release. Salesforce undertakes no obligation to update the information provided herein.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lilly-expands-use-of-salesforce-platform-to-build-more-apps-and-put-patients-at-the-center-of-their-care-300334562.html
SOURCE SalesforcePR Newswire
Last updated on: 27/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.